541 related articles for article (PubMed ID: 20386115)
1. Retrospective evaluation of the dexamethasone suppression test as a predictor of response to electroconvulsive therapy in patients with comorbid major depressive disorder and posttraumatic stress disorder.
Watts BV; Groft A
J ECT; 2010 Sep; 26(3):213-7. PubMed ID: 20386115
[TBL] [Abstract][Full Text] [Related]
2. Electroconvulsive therapy for comorbid major depressive disorder and posttraumatic stress disorder.
Watts BV
J ECT; 2007 Jun; 23(2):93-5. PubMed ID: 17548978
[TBL] [Abstract][Full Text] [Related]
3. EFFICACY AND LONG-TERM CLINICAL OUTCOME OF COMORBID POSTTRAUMATIC STRESS DISORDER AND MAJOR DEPRESSIVE DISORDER AFTER ELECTROCONVULSIVE THERAPY.
Ahmadi N; Moss L; Simon E; Nemeroff CB; Atre-Vaidya N
Depress Anxiety; 2016 Jul; 33(7):640-7. PubMed ID: 26555786
[TBL] [Abstract][Full Text] [Related]
4. The dexamethasone suppression test and ECT outcome: a six-month follow-up.
Coryell W; Zimmerman M
Biol Psychiatry; 1983 Jan; 18(1):21-7. PubMed ID: 6830923
[TBL] [Abstract][Full Text] [Related]
5. Treatment of comorbid posttraumatic stress disorder and major depressive disorder: a pilot study.
Nixon RD; Nearmy DM
J Trauma Stress; 2011 Aug; 24(4):451-5. PubMed ID: 21755543
[TBL] [Abstract][Full Text] [Related]
6. Changes in serial dexamethasone suppression tests among unipolar depressive receiving electroconvulsive treatment.
Albala AA; Greden JF; Tarika J; Carroll BJ
Biol Psychiatry; 1981 Jun; 16(6):551-60. PubMed ID: 7260217
[TBL] [Abstract][Full Text] [Related]
7. Dexamethasone suppression test in borderline personality disorder--effects of posttraumatic stress disorder.
Lange W; Wulff H; Berea C; Beblo T; Saavedra AS; Mensebach C; Wingenfeld K; Driessen M
Psychoneuroendocrinology; 2005 Oct; 30(9):919-23. PubMed ID: 15896918
[TBL] [Abstract][Full Text] [Related]
8. Differences in the response to the combined DEX-CRH test between PTSD patients with and without co-morbid depressive disorder.
de Kloet C; Vermetten E; Lentjes E; Geuze E; van Pelt J; Manuel R; Heijnen C; Westenberg H
Psychoneuroendocrinology; 2008 Apr; 33(3):313-20. PubMed ID: 18215470
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcome of maintenance electroconvulsive therapy in comorbid Posttraumatic Stress Disorder and major depressive disorder.
Ahmadi N; Moss L; Hauser P; Nemeroff C; Atre-Vaidya N
J Psychiatr Res; 2018 Oct; 105():132-136. PubMed ID: 30219562
[TBL] [Abstract][Full Text] [Related]
10. Specificity of posttraumatic stress disorder symptoms: an investigation of comorbidity between posttraumatic stress disorder symptoms and depression in treatment-seeking veterans.
Gros DF; Simms LJ; Acierno R
J Nerv Ment Dis; 2010 Dec; 198(12):885-90. PubMed ID: 21135640
[TBL] [Abstract][Full Text] [Related]
11. The DST as a predictor of acute response to treatment with ECT, chlorimipramine, amitriptyline, and phenelzine.
Modai I; Rinsky H; Cygielman G
J Clin Psychiatry; 1986 Mar; 47(3):139-40. PubMed ID: 3949722
[TBL] [Abstract][Full Text] [Related]
12. Post-dexamethasone cortisol as a predictor for the efficacy of electroconvulsive therapy in depressed inpatients.
Vukadin M; Birkenhäger TK; Wierdsma AI; Groenland TH; van den Broek WW
J Psychiatr Res; 2011 Sep; 45(9):1165-9. PubMed ID: 21481419
[TBL] [Abstract][Full Text] [Related]
13. Electroconvulsive therapy for depression with comorbid borderline personality disorder or post-traumatic stress disorder: A matched retrospective cohort study.
Kaster TS; Goldbloom DS; Daskalakis ZJ; Mulsant BH; Blumberger DM
Brain Stimul; 2018; 11(1):204-212. PubMed ID: 29111076
[TBL] [Abstract][Full Text] [Related]
14. Predicting efficacy of electroconvulsive therapy in major depressive disorder.
Tsuchiyama K; Nagayama H; Yamada K; Isogawa K; Katsuragi S; Kiyota A
Psychiatry Clin Neurosci; 2005 Oct; 59(5):546-50. PubMed ID: 16194256
[TBL] [Abstract][Full Text] [Related]
15. Predictors of response to electroconvulsive therapy obtained using the three-factor structure of the Montgomery and Asberg Depression Rating Scale for treatment-resistant depressed patients.
Okazaki M; Tominaga K; Higuchi H; Utagawa I; Nakamura E; Noguchi M; Itaya M; Hashimoto C; Yamaguchi N
J ECT; 2010 Jun; 26(2):87-90. PubMed ID: 19710622
[TBL] [Abstract][Full Text] [Related]
16. Posttraumatic stress disorder comorbidity in patients undergoing ECT for major depressive disorder.
Youssef NA; Brodsky L; Patel RS
Ann Clin Psychiatry; 2023 Nov; 35(4):223-227. PubMed ID: 37459495
[TBL] [Abstract][Full Text] [Related]
17. Enhanced cortisol suppression in response to dexamethasone administration in traumatized veterans with and without posttraumatic stress disorder.
de Kloet CS; Vermetten E; Heijnen CJ; Geuze E; Lentjes EG; Westenberg HG
Psychoneuroendocrinology; 2007 Apr; 32(3):215-26. PubMed ID: 17296270
[TBL] [Abstract][Full Text] [Related]
18. [Acute and chronic effects of electroconvulsive therapy on neuroactive steroids in patients with major depressive disorder].
Ozsoy S; Eşel E; Hacimusalar Y; Candan Z; Kula M; Turan T
Turk Psikiyatri Derg; 2008; 19(4):341-8. PubMed ID: 19110975
[TBL] [Abstract][Full Text] [Related]
19. Propofol and methohexital as anesthetic agents for electroconvulsive therapy: a randomized, double-blind comparison of electroconvulsive therapy seizure quality, therapeutic efficacy, and cognitive performance.
Geretsegger C; Nickel M; Judendorfer B; Rochowanski E; Novak E; Aichhorn W
J ECT; 2007 Dec; 23(4):239-43. PubMed ID: 18090696
[TBL] [Abstract][Full Text] [Related]
20. The influence of comorbid MDD on outcome after residential treatment for veterans with PTSD and a history of TBI.
Walter KH; Barnes SM; Chard KM
J Trauma Stress; 2012 Aug; 25(4):426-32. PubMed ID: 22821663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
